Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talarozole in moderate to severe plaque psoriasis
NCT00725348Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2004
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of talarozole in plaque psoriasis, sponsored by GSK. Started Apr 2004; status: completed.
02
Drugs
talarozole
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00725348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00725348.